Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.828 CHF | +9.95% | +32.89% | +33.77% |
Mar. 22 | Idorsia's Chief Medical Officer to Step Down at March-end; Successor Named | MT |
Mar. 20 | Transcript : Idorsia Ltd - Special Call |
Sales 2023 * | 119M 132M | Sales 2024 * | 214M 238M | Capitalization | 505M 560M |
---|---|---|---|---|---|
Net income 2023 * | -407M -451M | Net income 2024 * | -401M -444M | EV / Sales 2023 * | 12.8 x |
Net Debt 2023 * | 1.02B 1.13B | Net Debt 2024 * | 1.22B 1.35B | EV / Sales 2024 * | 8.05 x |
P/E ratio 2023 * |
-1.36
x | P/E ratio 2024 * |
-1.98
x | Employees | 650 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 58.67% |
Latest transcript on Idorsia Ltd
1 day | +9.95% | ||
1 week | +32.89% | ||
Current month | +26.70% | ||
1 month | +8.35% | ||
3 months | +28.55% | ||
6 months | +9.95% | ||
Current year | +33.77% |
Managers | Title | Age | Since |
---|---|---|---|
Jean-Paul Clozel
CEO | Chief Executive Officer | 68 | 17-05-31 |
André Muller
DFI | Director of Finance/CFO | 60 | 17-05-31 |
Guy Braunstein
CTO | Chief Tech/Sci/R&D Officer | 67 | 17-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
BRD | Director/Board Member | 65 | 20-05-12 |
Peter Kellogg
BRD | Director/Board Member | 68 | 21-05-11 |
Jean-Paul Clozel
CEO | Chief Executive Officer | 68 | 17-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 735 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.828 | +9.95% | 1,874,799 |
24-03-27 | 2.572 | +1.34% | 869,081 |
24-03-26 | 2.538 | +13.51% | 1,062,979 |
24-03-25 | 2.236 | +5.17% | 512,686 |
24-03-22 | 2.126 | -0.09% | 765,773 |
Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+33.77% | 561M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |